{"id":52048,"date":"2022-12-15T19:02:03","date_gmt":"2022-12-15T18:02:03","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-hpv-testing-and-pap-test-market-report-2022-to-2027-innovative-improvements-in-hpv-tests-presents-opportunities-researchandmarkets-com\/"},"modified":"2022-12-15T19:02:03","modified_gmt":"2022-12-15T18:02:03","slug":"global-hpv-testing-and-pap-test-market-report-2022-to-2027-innovative-improvements-in-hpv-tests-presents-opportunities-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-hpv-testing-and-pap-test-market-report-2022-to-2027-innovative-improvements-in-hpv-tests-presents-opportunities-researchandmarkets-com\/","title":{"rendered":"Global HPV Testing and Pap Test Market Report 2022 to 2027: Innovative Improvements in HPV Tests Presents Opportunities – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “HPV Testing and Pap Test Market by Test Type (HPV Testing (Follow-Up HPV Testing, Co-Testing, Primary HPV Testing), PAP Test), End User (Laboratories, Hospitals, Physician’s Offices & Clinics), Region – Global Forecast to 2027”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global HPV testing and Pap test market is projected to reach USD 9.2 billion by 2027 from USD 4.9 billion in 2022, at a CAGR of 13.2% during the forecast period.\n<\/p>\n

\nThe HPV testing segment accounted for the highest growth rate in the HPV testing and Pap test market, by test type, during the forecast period<\/strong>\n<\/p>\n

\nThe HPV testing and Pap test market is segmented into HPV testing and Pap test. In 2021, HPV testing segment accounted for the highest growth rate in the HPV testing and Pap test market. Increase in number of product approval and increased focus on reducing cancer cases are major factor contributing to the growth of this segment.\n<\/p>\n

\nThe cervical cancer screening segment accounted for the highest growth rate in the HPV testing and Pap test market, by application, during the forecast period\n<\/p>\n

\nThe HPV testing and Pap test market is segmented into cervical cancer screening and vaginal cancer screening. In 2021, HPV testing segment accounted for the highest growth rate in the HPV testing and Pap test market. Increasing funding for the prevention of cervical cancer are major factors contributing to the growth of this segment.\n<\/p>\n

\nThe hospitals segment accounted for the highest growth rate in the HPV testing and Pap test market, by end user, during the forecast period<\/strong>\n<\/p>\n

\nThe HPV testing and Pap test market is segmented into laboratories, hospitals and physician’s offices & clinics based on end user. In 2021, the hospitals segment accounted for the highest growth rate in the HPV testing and Pap test market. Emerging markets offering lucrative growth opportunities are major factors contributing to the growth of this segment.\n<\/p>\n

\nAsia Pacific: The fastest-growing region in HPV testing and Pap test market<\/strong>\n<\/p>\n

\nThe global HPV testing and Pap test market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Increasing number of conferences focused on creating awareness of cervical cancer is driving the growth of the HPV testing and Pap test market in this region.\n<\/p>\n

\nMarket Dynamics<\/strong>\n<\/p>\n

\nDrivers<\/em><\/strong>\n<\/p>\n